Parlier V, Tiainen M, Beris P, Miescher P A, Knuutila S, Jotterand Bellomo M
Division de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Br J Haematol. 1992 Jun;81(2):296-304. doi: 10.1111/j.1365-2141.1992.tb08223.x.
Paroxysmal nocturnal haemoglobinuria (PNH) was diagnosed in a 20-year-old male patient who suffered from anaemia since the age of 11. Eighteen years after diagnosis, PNH transformed into refractory anaemia with ringed sideroblasts (RARS). Trisomy 8 was observed in 27%, 45% and 53% of the bone marrow metaphase cells analysed in 1987, 1988 and 1990 respectively. In order to determine which bone marrow cell lineages were affected by trisomy 8 and at which stage of stem cell differentiation, MAC (Morphology, Antibody, Chromosomes) and CISS (Chromosomal In Situ Suppression) hybridization techniques were combined. The MAC technique enables karyotypic analysis of morphologically and immunologically classified mitotic cells. CISS hybridization makes it possible to detect individual chromosomes and chromosome aberrations using recombinant DNA libraries from sorted human chromosomes. Trisomy 8 was detected in granulomonocytic (50.6%), erythrocytic (67.2%) and megakaryocytic (one megakaryocyte with trisomy 8, one normal) lineages, providing evidence for the occurrence of trisomy 8 in early haematopoietic cell precursors, at the GEMM or pluripotent level. Cytogenetic and clinical data suggest that the sideroblastic clone originated from a mutation affecting a cell of the PNH clone, progressively replaced by the PNH/RARS clone, due to proliferative advantage.
一名自11岁起就患有贫血的20岁男性患者被诊断为阵发性夜间血红蛋白尿(PNH)。诊断18年后,PNH转变为环形铁粒幼细胞难治性贫血(RARS)。分别在1987年、1988年和1990年分析的骨髓中期细胞中,8号染色体三体的检出率分别为27%、45%和53%。为了确定8号染色体三体影响哪些骨髓细胞谱系以及在干细胞分化的哪个阶段发生影响,将形态学、抗体、染色体(MAC)和染色体原位抑制(CISS)杂交技术结合起来。MAC技术能够对形态学和免疫分类的有丝分裂细胞进行核型分析。CISS杂交使得利用来自分选的人类染色体的重组DNA文库检测单个染色体和染色体畸变成为可能。在粒单核细胞系(50.6%)、红细胞系(67.2%)和巨核细胞系(一个8号染色体三体的巨核细胞,一个正常)中检测到8号染色体三体,这为8号染色体三体在早期造血细胞前体(即粒、红、巨核系祖细胞或多能水平)中发生提供了证据。细胞遗传学和临床数据表明,铁粒幼细胞克隆起源于影响PNH克隆细胞的一个突变,由于增殖优势,逐渐被PNH/RARS克隆所取代。